Send feedback

HTT p.Pro703Leu

c.2108C>T · rs768047421 · VCV417742

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.3045 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0504%, mid)
Missense predictors
1/2 damaging
AlphaMissense, REVEL · SaProt no call
Conditions
2
Huntington disease

Computational evidence

Protein change
AlphaMissense0.3045likely benign
REVEL0.657pathogenic-leaning
SaProt—not scored · why
⇒ REVEL calls this damaging; AlphaMissense does not; SaProt makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.4GERP 1.1, phastCons 0.79
Overall
CADD25.7PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0504% Middle Eastern · 3/5,956 alleles
Filtering AF 0.0136% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00736%
Overall 0.00428% 69/1,612,578 alleles · ultra-rare exomes 63/1,460,470 · genomes 6/152,108 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.088% 1,136
Middle Easterngrpmax 0.0504% 1,985
South Asian 0.0154% 6,499
Remaining individualsnot grpmax-eligible 0.00801% 12,483
African / African-American 0.00401% 24,939
East Asian 0.00223% 44,852
Admixed American 0.00167% 59,704
European (non-Finnish) 0.00136% 73,712

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
HTT
Protein
p.Pro703Leu
Coding
c.2108C>T
MANE Select
NM_001388492
dbSNP
rs768047421
Type
single nucleotide variant
Location
chr4:3131647 (GRCh38)
Structure
AlphaFold pLDDT 85.38 · 30 PDB
Full HTT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Huntington disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: Lopes-Maciel-Rodan syndrome

For Huntington disease (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Elderly
Prevalence
1-9 / 100 000 (Greece)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/htt-p-pro703leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown